Atlas Trials

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment

Clinical trial NCT07152288 · RECRUITING

Trial details

NCT number
NCT07152288
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Start date
2025-05-29
Primary completion
2025-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.